NDRA

ENDRA Life Sciences Inc

NDRA, USA

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

https://endrainc.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NDRA
stock
NDRA

How DAKT stock trades during market volatility - Earnings Performance Report & Weekly Top Gainers Trade List bollywoodhelpline.com

Read more →
NDRA
stock
NDRA

Can The Boeing Company be the next market leader - Earnings Recap Summary & High Return Trade Guides baoquankhu1.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$30

Analyst Picks

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

0.22

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

19.90

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-931.24 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-81.26 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very Low

10.46

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 1.31% of the total shares of ENDRA Life Sciences Inc

1.

UBS Group AG

(0.6237%)

since

2025/06/30

2.

Fidelity Extended Market Index

(0.5112%)

since

2025/07/31

3.

Fidelity Series Total Market Index

(0.0917%)

since

2025/07/31

4.

Spartan Total Market Index Pool G

(0.062%)

since

2025/07/31

5.

Vanguard Institutional Extnd Mkt Idx Tr

(0.0154%)

since

2025/07/31

6.

Northwestern Mutual Wealth Management Co

(0.0046%)

since

2025/06/30

7.

Spartan Extended Market Index Pool F

(0.0036%)

since

2025/07/31

8.

Bank of America Corp

(0.0008%)

since

2025/06/30

9.

NT Ext Equity Mkt Idx Fd - L

(0.0005%)

since

2025/06/30

10.

Northern Trust Extended Eq Market Idx

(0.0005%)

since

2025/06/30

11.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0001%)

since

2024/12/31

12.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0001%)

since

2025/06/30

14.

Tower Research Capital LLC

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-2.1

EPS Estimate

-0.25

EPS Difference

-1.85

Surprise Percent

-740%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1)
Economic Moat
No Clear Moat(2.8)
GARP
Not Attractive for GARP(0.5)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(1.5)
Quality
Low Quality Business(1)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.